| |
|
 |
|
|
NYSE EURONEXT
NYSE Euronext, a holding company created by the combination of NYSE Group, Inc. and Euronext N.V., commenced trading on April 4, 2007 . NYSE Euronext (NYSE Euronext: NYX) operates the world's largest and most liquid exchange group and offers the most diverse array of financial products and services. NYSE Euronext, which brings together six cash equities exchanges in five countries and six derivatives exchanges in six countries, is a world leader for listings, trading in cash equities, equity and interest rate derivatives, bonds and the distribution of market data. Representing a combined $30.3 trillion/EUR21.3 trillion total market capitalization of listed companies and average daily trading value of approximately $139 billion/EUR103 billion (as of September 30, 2007), NYSE Euronext seeks to provide the highest standards of market quality and integrity, innovative products and services to investors, issuers, and all users of its markets.
BAKER & MCKENZIE
Baker & McKenzie Amsterdam is a leading Dutch law firm focusing on providing innovative legal services to clients in the business community. Baker & McKenzie Amsterdam has over 50 years of experience in international and national legal practice.
We represent Venture Capital & Private Equity Investors in a broad variety of industries, with extensive experience and a proven track record in Biotech and Pharmaceuticals. We are able to efficiently deliver the specialized knowledge crucial to evaluating, structuring, consummating and exiting investments of all kinds.
Baker & McKenzie also represents investee companies within and across all domestic and global markets. We work with entrepreneurs and established management teams to structure and form entities of all kinds, assist with the negotiation and consummation of equity and debt financing crucial to the success of every enterprise.
BIRD & BIRD
As the understanding of the life sciences increases so the complexity and diversity of corporate and commercial transactions in this sector also increases. At Bird & Bird we have built our International Life Sciences Group on the belief that deep understanding of the science that drives this sector forward goes hand in hand with providing the legal advice that helps secure commercial developments. It is this combination of knowledge that enables us to provide our clients with practical and commercial advice that helps them to realize their business goals.
Bird & Bird have an enviable reputation acting for biotechnology, bioinformatics and pharmaceutical companies. Our practice covers the full range of services from the incorporation, development and financing of bioscience businesses and the exploitation of their intellectual property assets to main stream high value litigation of pharmaceutical patents.
PRICEWATERHOUSECOOPERS
At PricewaterhouseCoopers Nederland, over 4,500 professionals work together covering various disciplines: Assurance, Tax and Human Resource Services, and Advisory. On the basis of our corporate philosophy, Connected Thinking, we provide sector-specific services and seek novel solutions. Not only for large national and international companies, but also for medium-sized and smaller businesses as well as for government entities and non-profit organisations.
As an independent part of a worldwide network comprising 140,000 colleagues in 149 countries, we can rely on extensive knowledge and experience which we share with each other, with our clients and with their stakeholders. We seek unexpected angles, make surprising connections, feel involved and work together from our strengths.
LOVELLS
Lovells are Tea and Coffee sponsors at BioCapital Europe 2008.
Lovells is one of the pre-eminent international law firms advising on contentious and non-contentious issues in the pharmaceutical, biosciences and medical devices industries. We advise clients on all matters relating to the full pharma/biotech product life cycle, from clinical trial agreements through to off patent strategy and from early stage financing to IPO or M&A consolidation. Life sciences is a core sector for the firm. Our group of industry specialists consists of pharma lawyers in all major jurisdictions, many of whom are scientifically qualified. The team comprises experts in intellectual property, corporate, equity capital markets, competition, product liability, regulatory, IT and dispute resolution. Lovells combines this expertise with a wide experience in the fields of IPO's, M&A and finance offering a full legal service for all our life sciences and venture capital clients.
The Amsterdam office comprises six practice areas:
* Corporate, M&A
Contact partners: Johannes Buntjer; Victor de Vlaam and Jan de Snaijer (civil law notary);
* Intellectual Property / Information Technology & Regulated Markets
Contact partners: Klaas Bisschop, Bert Oosting and Marc Wallheimer;
* Banking & Finance, Business Restructuring & Capital Markets
Contact partner: Ken Breken;
* Litigation & Arbitration
Contact partners: Klaas Bisschop and Bert Oosting.
* Tax
Contact partner: Anton Louwinger;
* Employment
Contact partner: Anita de Jong;
* Litigation & Arbitration
Contact partners: Klaas Bisschop and Bert Oosting.
The local managing partner of Lovells Amsterdam is Klaas Bisschop (39) effective from 1 January 2007.
ERNST & YOUNG
Keywords defining Ernst & Young Health Sciences are Quality and Global leadership. We audit more then half of the companies that make up the Nasdaq Biotechnology Index. For 17 years we have captured market insights with our annual authoritative biotechnology reports. Our reports are widely cited in the media and are used by many of our clients, industry analysts and other experts covering the sector. Our auditors, tax, legal and business advisors work in multidisciplinary teams, dedicated to selected industries. Worldwide, 7.500 Ernst & Young professionals devote at least half of their working life to serving life sciences companies.
Among other things, we can help with: finding grant money, optimising legal and tax structures, due diligence, management renumeration/option plans,improving cash management systems, registration and protection of intellectual property,identifying key business risks or developing effective reporting procedures for management and/or stakeholders.
KPMG
KPMG Netherlands offers services in the fields of audit, tax and advisory. We offer our services to a broad group of clients: major domestic and international companies, medium-sized enterprises, non-profit organisations and government institutions. The complicated problems faced by our clients require a multidisciplinary approach. Our professionals stand out in their own specialist fields while, at the same time, working together to offer added value that enables our clients to excel in their own environment. In doing so, we draw from a rich source of knowledge and experience, gained worldwide in the widest range of different organisations and markets. We provide real answers so that our clients can take better decisions.
Amsterdam Innovation Motor
Find your life sciences partner in the Amsterdam BioMed Cluster! - www.amsterdambiomed.com
The Amsterdam Metropolitan Area is home to an impressive number of companies and knowledge institutes active in the life sciences. The Amsterdam BioMed Cluster has been set up to gain economical spin off of the bio- and medical technology in the region.
Apart from building a dynamic community to exploit synergy between the life sciences organisations present in the region, the objective of the Amsterdam BioMed Cluster is to open up our regional knowledge- and technology base to those, national and international, parties interested in doing business with us.
The Amsterdam BioMed Cluster is hosted by the Amsterdam Innovation Motor, a not for profit organisation.
|
|
|
